Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.

Bill: 117-hres-1284
Sponsor: full_name: Rep. McMorris Rodgers, Cathy [R-WA-5]
Introduced: 2022-07-26
Policy area: Health
Subjects: Congressional oversight

Government information and archives

Medicare

Prescription drugs
Latest action: action_date: 2022-09-30
text: Placed on the House Calendar, Calendar No. 140.

Summaries:
action_date: 2022-07-26
action_desc: Introduced in House
text: <p>This resolution directs the Department of Health and Human Services (HHS) to furnish to the House of Representatives any external or internal communications of the White House regarding the implications of imposing certain penalties on drug manufacturers that do not comply with HHS price negotiations under the Medicare prescription drug benefit.</p>

action_date: 2022-09-30
action_desc: Reported to House
text: <p>This resolution directs the Department of Health and Human Services (HHS) to furnish to the House of Representatives any external or internal communications of the White House regarding the implications of imposing certain penalties on drug manufacturers that do not comply with HHS price negotiations under the Medicare prescription drug benefit.</p>

tv_txt: IV 117th CONGRESS 2d Session H. RES. 1284 IN THE HOUSE OF REPRESENTATIVES July 26, 2022 Mrs. Rodgers of Washington submitted the following resolution; which was referred to the Committee on Energy and Commerce RESOLUTION Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.

That the Secretary of Health and Human Services (referred to herein as the Secretary ) is directed to furnish to the House of Representatives, not later than 14 days after adoption of this resolution, copies of any document, record, audio recording, memorandum, call log, correspondence (electronic or otherwise), or other communication in the Secretary’s possession, or any portion of any document, record, audio recording, memorandum, call log, correspondence (electronic or otherwise), or other communication in the Secretary’s possession, that refers or relates to any of the following: (1) Communications by staff of the White House with any group or expert that is not staff of the White House regarding the implications of imposing a 95 percent excise tax on drug manufacturers that fail to comply with price setting negotiations with the Secretary under the Medicare prescription drug program under part D of title XVIII of the Social Security Act and the potential loss of the development of future drugs and cures. (2) Internal communications among staff of the White House regarding the implications described in paragraph (1) and the potential loss of development described in such paragraph. (3) Communications by staff of the White House with any group or expert that is not staff of the White House regarding the implications of establishing inflation penalties under the Medicare prescription drug program under such part D on launch prices for future prescription drugs. (4) Internal communications among staff of the White House regarding the implications described in paragraph (3).

tv_txt: IV House Calendar No. 140 117th CONGRESS 2d Session H. RES. 1284 [Report No. 117–534] IN THE HOUSE OF REPRESENTATIVES July 26, 2022 Mrs. Rodgers of Washington submitted the following resolution; which was referred to the Committee on Energy and Commerce September 30, 2022 Reported adversely from the Committee on Energy and Commerce , referred to the House Calendar, and ordered to be printed RESOLUTION Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.

That the Secretary of Health and Human Services (referred to herein as the Secretary ) is directed to furnish to the House of Representatives, not later than 14 days after adoption of this resolution, copies of any document, record, audio recording, memorandum, call log, correspondence (electronic or otherwise), or other communication in the Secretary’s possession, or any portion of any document, record, audio recording, memorandum, call log, correspondence (electronic or otherwise), or other communication in the Secretary’s possession, that refers or relates to any of the following: (1) Communications by staff of the White House with any group or expert that is not staff of the White House regarding the implications of imposing a 95 percent excise tax on drug manufacturers that fail to comply with price setting negotiations with the Secretary under the Medicare prescription drug program under part D of title XVIII of the Social Security Act and the potential loss of the development of future drugs and cures. (2) Internal communications among staff of the White House regarding the implications described in paragraph (1) and the potential loss of development described in such paragraph. (3) Communications by staff of the White House with any group or expert that is not staff of the White House regarding the implications of establishing inflation penalties under the Medicare prescription drug program under such part D on launch prices for future prescription drugs. (4) Internal communications among staff of the White House regarding the implications described in paragraph (3).

September 30, 2022 Reported adversely from the Committee on Energy and Commerce , referred to the House Calendar, and ordered to be printed